SCHEDULE 13D/A Filed 2026-05-11 Event 2026-05-07 SEC 0001104659-26-058726 →

BAKER BROS. ADVISORS LP → Incyte Corp INCY

Stake: — Shares: 30,865,077 Class: Common Stock, $0.001 par value per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

8 13D/G filings on this issuer

7 other filings besides this one

Filer Track Record

67 filings by this filer

66 other filings in the data moat

Short Interest · settle 2026-09-30

DTC 6.06

9,987,084 shares short · +0.1% vs prior

Post-Filing Returns · since 2026-05-07 on INCY

+1 day

0.0%

+5 days

0.0%

+30 days

0.0%

+60 days

0.0%

+90 days

—

+180 days

—

Anchor price 118.05 on closest trading day on/after 2026-05-07. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on Incyte Corp

Filed	Form	Filer	Stake	Shares
2024-06-14	SC	BAKER BROS. ADVISORS LP	—	—	view →
2023-03-15	SC	BAKER BROS. ADVISORS LP	—	—	view →
2022-02-14	SC	BAKER BROS. ADVISORS LP	—	—	view →
2021-05-18	SC	BAKER BROS. ADVISORS LP	—	—	view →
2020-04-29	SC	BAKER BROS. ADVISORS LP	—	—	view →
2019-06-07	SC	BAKER BROS. ADVISORS LP	—	—	view →
2018-05-03	SC	BAKER BROS. ADVISORS LP	—	—	view →

Other Filings by BAKER BROS. ADVISORS LP

Filed	Form	Issuer	Stake	Shares
2026-09-30	SCHEDULE 13D/A	Kodiak Sciences Inc.	35.00%	22,049,297	view →
2026-09-16	SCHEDULE 13D/A	BeOne Medicines Ltd.	—	115,457,154	view →
2026-08-11	SCHEDULE 13D/A	Replimune Group, Inc.	11.80%	11,075,336	view →
2026-07-16	SCHEDULE 13D/A	Celcuity Inc.	9.99%	4,877,963	view →
2026-07-16	SCHEDULE 13G	Celcuity Inc.	—	—	view →
2026-06-15	SCHEDULE 13D/A	BeOne Medicines Ltd. BEIGF	8.00%	115,457,154	view →
2026-05-26	SCHEDULE 13D/A	Kiniksa Pharmaceuticals International, plc KNSA	7.00%	3,231,181	view →
2025-06-30	SCHEDULE	Kymera Therapeutics, Inc. KYMR	9.50%	6,666,540	view →
2024-10-08	SC	Kiniksa Pharmaceuticals International, plc KNSA	—	—	view →
2024-06-14	SC	INCYTE CORP INCY	—	—	view →
2023-12-18	SC	Seagen Inc.	—	—	view →
2023-10-10	SC	Neoleukin Therapeutics, Inc. NGNE	—	—	view →
2023-10-05	SC	MADRIGAL PHARMACEUTICALS, INC. MDGL	—	—	view →
2023-07-19	SC	Neoleukin Therapeutics, Inc. NGNE	—	—	view →
2023-05-24	SC	Prelude Therapeutics Inc PRLD	—	—	view →
2023-05-24	SC	ACADIA PHARMACEUTICALS INC ACAD	—	—	view →
2023-05-03	SC	Seagen Inc.	—	—	view →
2023-03-15	SC	INCYTE CORP INCY	—	—	view →
2023-03-13	SC	Seagen Inc.	—	—	view →
2023-01-17	SC	ACADIA PHARMACEUTICALS INC ACAD	—	—	view →

Showing 20 of 66

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →